Identifying pathogenic proteins leads to potential new treatments for diseases such as diabetes.

Published Date: 02 Mar 2023

New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.

Read Full News

Latest News

Can Gut Bacterium Supplement Lead to Less Weight Regain?

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

Stress, BMI Linked to Earlier Puberty in Girls

Higher levels of non-estrogen hormones, along with stress and elevated BMI, are linked to earlier breast development in girls.

As GLP-1 Uptake Rises, Metabolic Surgery Rates Decline

Metabolic bariatric surgery use declined by 34.1% from 2022 through 2024, whereas GLP-1 prescriptions increased by more than 140% during the same period.

Did Hyperglycemia Affect Inavolisib-Efficacy in BC Patients?

Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with numerically better outcomes among patients who develop the metabolic side effect.

Patients Over 65 With Obesity Respond Well to Semaglutide

In a pooled analysis of the STEP trials, semaglutide produced substantial weight loss and cardiometabolic improvements in adults aged 65 years or older.

How Bariatric Surgery Shapes IBD Risk Over Time in Obesity

In patients with severe obesity, metabolic and bariatric surgery was linked to a lower risk for inflammatory bowel disease within 3 years but a higher risk over longer follow-up.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Latest News

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

Higher levels of non-estrogen hormones, along with stress and elevated BMI, are linked to earlier breast development in girls.

Metabolic bariatric surgery use declined by 34.1% from 2022 through 2024, whereas GLP-1 prescriptions increased by more than 140% during the same period.

Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with numerically better outcomes among patients who develop the metabolic side effect.

In a pooled analysis of the STEP trials, semaglutide produced substantial weight loss and cardiometabolic improvements in adults aged 65 years or older.

In patients with severe obesity, metabolic and bariatric surgery was linked to a lower risk for inflammatory bowel disease within 3 years but a higher risk over longer follow-up.

News All Time

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Many Older Patients Can Ditch Common Thyroid Drug, Study Suggests

Experts call for better guidance on levothyroxine initiation, deprescribing

GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics

News and commentary from the endocrinology world

Drug Manufacturer Coupon Use; Cholesterol Targets for Secondary Prevention

Also in TTHealthWatch: deprescribing levothyroxine

Call to Integrate Obesity Management With Surgery, GLP-1s Into Cancer Care

"Most effective therapies" underutilized, say authors, but oncologist cites lack of quality data

Further Doubt on Heart-Healthiness of Calcium Supplements

Recurrent cardiovascular events increased in a large cohort study

Are GLP-1 Drugs Linked to Erectile Dysfunction?

Real-world study in type 2 diabetes suggests possible association, but more research is needed

Meal Monotony for Weight Loss; Genes Explain GLP-1 Response; Menopause Drug Boom

News and commentary from the endocrinology world

New GLP-1 Side Effect? Highest-Burnout Specialties; Trump's Psychedelic Plan

Health news and commentary gathered by MedPage Today staff

FDA Takes Steps to Expand Testosterone for Men's Libido

Agency last year removed boxed warning about risks for heart attack and stroke

Mobile Intervention Helps Moms With Obesity Reduce Gestational Weight Gain

Intervention uses a smartphone app to promote healthy eating and increased activity

Study Warns of High-Risk Group for Fatal Liver Disease

Risky drinking and obesity "contribute synergistically" to rising rates of liver disease, death

Recommended News For You

A new therapeutic approach could help tackle radiation resistance in childhood brain tumors

Health researchers discuss Medicaid cancer screening trends, best practices

Do Anatomy Atlases Reflect Social Inequalities?

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis

Recommended Articles For You

The Role of Calcium Corrections in Accurate Blood Test Results  

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals 

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies  

Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The response of bipolar patients to lithium may be predicted by ancestry.

2.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

3.

Do Anatomy Atlases Reflect Social Inequalities?

4.

Modified personalized cancer vaccine generates powerful immune response

5.

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

1.

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target

2.

Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment

3.

Understanding SVR Normal Range: A Guide to Achieving Optimal Health

4.

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies

5.

AI in Cancer Diagnostics and Imaging Interpretation

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Should We Use DARA Up Front As First-Line Therapy in MM?

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

3.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot